The Oncological Virtual Living Lab is an open innovation ecosystem designed to advance gender-sensitive, cutting-edge solutions for colorectal cancer (CRC) screening and early detection across Europe. Rooted in the Living Lab methodology, it serves as a real-life experimentation and co-creation environment, where key stakeholders—including citizens, healthcare professionals, researchers, policymakers, and industry leaders—collaborate to drive impactful innovation in CRC prevention and diagnosis.
Living Labs as real-life test and experimentation environments, foster co-creation and open innovation among the main actors of the Quadruple Helix Model, namely: Citizens (Community), Government, Industry, Academia
The Oncological Virtual Living Lab operates through a Quadruple Helix Model, bringing together key stakeholders from Academia, Industry, Government, and Citizens to co-create cutting-edge colorectal cancer (CRC) screening solutions. Each partner plays a crucial role in fostering open innovation, ensuring that our advancements are scientifically robust, technologically feasible, policy-supported, and patient-centered.
Our Partners by Quadruple Helix approach:
- Catalink Limited
- AINIGMA Technologies B.V.
- Scientific Academy for Service Technology
- Konnektable Technologies Ltd
- BEIA Consult International
- Youth Cancer Europe
- European Society of Digestive Oncology
- Hellenic Society of Gastrointestinal Oncology
- Europacolon Portugal
- Consejo Superior de Investigaciones Científicas, Institute of Mathematical Sciences, DataLab
- ROSENBAUM Group
- CCassured
- INNOVATION SPRINT
- Portuguese Oncology Institute of Porto
- Institutul Oncologic Prof. Dr. Alexandru Trestioreanu București
- Israel Institute of Technology
- Firalis S.A.
Our Living Lab Working Groups
The Oncological Virtual Living Lab operates through dedicated working groups, ensuring a collaborative, multidisciplinary approach to developing innovative colorectal cancer (CRC) screening solutions. Each group plays a crucial role in shaping policies, advancing research, and ensuring patient-centered innovation.
Policy & Strategy Group
Focuses on regulatory alignment, funding opportunities, and integrating CRC screening innovations into healthcare policies.
Expert Advisory Group
Brings together oncologists, researchers, and industry professionals to drive cutting-edge, evidence-based CRC screening solutions.
Patient & Community Group
Ensures patient-centered innovation by incorporating the voices, needs, and experiences of patients and advocacy organizations.
Want to contribute?
If you are interested in joining one of our working groups, please contact us at irina.kolomiiets@lsmu.lt.